| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.12 | 4e-05 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0005 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |